Patrick Ott, Md, Phd

This early-stage study is testing the safety of a new, personalized vaccine designed to stop kidney cancer from returning after surgery. The vaccine is custom-made for each patient using unique markers from their own tumor. Researchers combine this vaccine with an approved immuno…